Antivirals Flashcards
anti-herpes drugs (acyclovir) mechanism of action
*acyclic guanosine analogues with high affinity for phosphorylation by VIRAL thymidine kinase
*once triphosphorylated, it prevents viral replication by inhibiting DNA polymerase
acyclovir spectrum
active against HSV-1, HSV-2, and VZV
acyclovir - mechanism of resistance
MUTATION in viral thymidine kinase (or TK deficiency)
valacyclovir benefits and indications
*better intracellular concentration and bioavailability (prodrug esters)
*works better against VZV than acyclovir
ganciclovir - overview
*mechanism of action and resistance similar to that of acyclovir
*more active against CMV!
ganciclovir indications
CMV infections in immunocompromised people and/or severe CMV infections
*IV only (valganciclovir is oral form)
ganciclovir toxicity
**bone marrow suppression (myelosuppression)
foscarnet - mechanism of action
*DIRECTLY inhibits DNA polymerase of human herpesviruses
foscarnet - indications
used for resistant herpesviruses (HSV, VZV, and CMV)
foscarnet - toxicities
*nephrotoxicity
*electrolyte disturbances
cidofovir - overview
novel nucleotide analog
*uses CELLULAR (host) thymidine kinases to produce the diphosphate form
M2 protein inhibitors
*amantadine and rimantadine
*used for influenza A only
neuraminidase inhibitors
*oseltamivir and zanamivir
*active against influenza A and B
when are the neuraminidase inhibitors helpful against influenza
*when started within 48 hours of symptom onset
*can also be used for influenza prophylaxis
NA inhibitors (oseltamivir) - toxicities
nausea and vomiting
ribavirin - mechanism of action
phosphorylated metabolites inhibit viral nucleaic acid synthesis
ribavirin - uses
RSV, hantavirus
ribavirin - toxicity
teratogenic
drugs for treatment of Hep B
all nucleoside analogues:
*lamiviudine (also for HIV)
*adefovir
*tenofovir (also for HIV)
telbivudine
**entecavir - best if not HIV+
treatments for hep C
direct acting antiviral drugs (replication inhibitors and protease inhibitors)
*can CURE hep C
remdesiver - mechanism of action & indication
*COVID-19 in hospitalized pts (IV only)
*MOA: inhibits viral RNA-dependent RNA polymerase
paxlovid - mechanism of action and indications
*COVID-19 (outpatient; oral)
*MOA: inhibits viral protease MPRO